{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:01:58Z","timestamp":1740106918140,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00277-024-06044-9","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T02:01:43Z","timestamp":1729044103000},"page":"6007-6013","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ischemic stroke as a presenting feature of promyelocytic blast phase in chronic myeloid leukemia \u2013 an uncommon presentation: a case report and literature review in the post imatinib era"],"prefix":"10.1007","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3014-573X","authenticated-orcid":false,"given":"Swapnil","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinu Balraam","family":"K. V.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3566-7484","authenticated-orcid":false,"given":"Amiya Ranjan","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richa","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3147-8643","authenticated-orcid":false,"given":"Jasmita","family":"Dass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Naranje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9885-1625","authenticated-orcid":false,"given":"Mukul","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"issue":"1","key":"6044_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1182\/blood-2002-02-0545","volume":"101","author":"HM Kantarjian","year":"2003","unstructured":"Kantarjian HM, Cortes JE, O\u2019Brien S, Giles F, Garcia-Manero G, Faderl S et al (2003) Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia: high incidence of early complete and major cytogenetic responses. Blood 101(1):97\u2013100","journal-title":"Blood"},{"issue":"23","key":"6044_CR2","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1056\/NEJMoa062867","volume":"355","author":"BJ Druker","year":"2006","unstructured":"Druker BJ, Guilhot F, O\u2019Brien SG, Gathmann I, Kantarjian H, Gattermann N et al (2006) Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 355(23):2408\u20132417","journal-title":"N Engl J Med"},{"issue":"22","key":"6044_CR3","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1002\/cncr.30864","volume":"123","author":"P Jain","year":"2017","unstructured":"Jain P, Kantarjian H, Ghorab A, Sasaki K, Jabbour E, Gonzalez GN et al (2017) Prognostic factors and survival outcomes in patients with blast phase CML (CML-BP) in the tyrosine kinase inhibitor (TKI) era: cohort study of 477 patients. Cancer 123(22):4391\u20134402","journal-title":"Cancer"},{"issue":"11","key":"6044_CR4","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1182\/blood-2003-12-4111","volume":"103","author":"B Calabretta","year":"2004","unstructured":"Calabretta B, Perrotti D (2004) The biology of CML blast crisis. Blood 103(11):4010\u20134022","journal-title":"Blood"},{"issue":"7","key":"6044_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1056\/NEJMoa040258","volume":"351","author":"CHM Jamieson","year":"2004","unstructured":"Jamieson CHM, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL et al (2004) Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 351(7):657\u2013667","journal-title":"N Engl J Med"},{"issue":"5","key":"6044_CR6","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1182\/blood-2010-12-326405","volume":"118","author":"S Soverini","year":"2011","unstructured":"Soverini S, Hochhaus A, Nicolini FE, Gruber F, Lange T, Saglio G et al (2011) BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet. Blood 118(5):1208\u20131215","journal-title":"Blood"},{"key":"6044_CR7","first-page":"283","volume":"38","author":"HJ Chung","year":"2008","unstructured":"Chung HJ, Chi HS, Cho YU, Park CJ, Seo EJ, Kim KH et al (2008) Promyelocytic blast crisis of chronic myeloid leukemia during imatinib treatment. Ann Clin Lab Sci 38:283\u2013286","journal-title":"Ann Clin Lab Sci"},{"key":"6044_CR8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7217","author":"M Parsi","year":"2020","unstructured":"Parsi M, Budak-Alpdogan T (2020) Promyelocytic blast crisis of chronic myeloid leukemia in a patient undergoing therapy with a tyrosine kinase inhibitor. Cureus. https:\/\/doi.org\/10.7759\/cureus.7217","journal-title":"Cureus"},{"issue":"3","key":"6044_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3343\/alm.2021.41.3.328","volume":"41","author":"B Kim","year":"2021","unstructured":"Kim B, Chi HY, Yoon YA, Choi Y-J (2021) Promyelocytic blast phase of chronic myeloid leukemia, BCR-abl1-positive: points to be considered at diagnosis. Annals Lab Med 41(3):328\u2013332. https:\/\/doi.org\/10.3343\/alm.2021.41.3.328","journal-title":"Annals Lab Med"},{"key":"6044_CR10","doi-asserted-by":"publisher","unstructured":"Wolanin S, McCall RK, Pettenati MJ, Beaty MW, Insuasti-Beltran G, Powell BL et al PML-rara fusion transcripts detectable 8 months prior to promyelocytic blast crisis in chronic myeloid leukemia. Case Rep Hematol 2020 Sept 1;2020:1\u20138. https:\/\/doi.org\/10.1155\/2020\/8830595","DOI":"10.1155\/2020\/8830595"},{"key":"6044_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000097920","volume":"117","author":"E Oku","year":"2007","unstructured":"Oku E, Imamura R, Nagata S, Takata Y, Seki R, Otsubo K et al (2007) Promyelocytic crisis of chronic myelogenous leukaemia during imatinib mesylate treatment. Acta Haematol 117:191\u2013196","journal-title":"Acta Haematol"},{"issue":"4","key":"6044_CR12","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1159\/000099548","volume":"117","author":"A Gozzetti","year":"2007","unstructured":"Gozzetti A, Bocchia M, Calabrese S, Pirrotta MT, Crupi R, Raspadori D et al (2007) Promyelocytic blast crisis of chronic myelogenous leukemia during imatinib treatment. Acta Haematol 117(4):236\u2013237. https:\/\/doi.org\/10.1159\/000099548","journal-title":"Acta Haematol"},{"issue":"4","key":"6044_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12308-012-0172-6","volume":"6","author":"D Hoehn","year":"2012","unstructured":"Hoehn D, Lu G, Konoplev S, Zhou Y, Bueso-Ramos CE, Zuo Z et al (2012) T (15;17) (q24.1;Q21.2)\/PML-RARA in blast phase of chronic myelogenous leukemia: a rare form of Clonal Evolution. J Hematopathology 6(4):187\u2013193. https:\/\/doi.org\/10.1007\/s12308-012-0172-6","journal-title":"J Hematopathology"},{"issue":"9","key":"6044_CR14","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1111\/j.1538-7836.2005.01467.x","volume":"3","author":"V De Stefano","year":"2005","unstructured":"De Stefano V, Sor\u00e0 F, Rossi E, Chiusolo P, Laurenti L, Fianchi L et al (2005) The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost 3(9):1985\u20131992","journal-title":"J Thromb Haemost"},{"issue":"5\u20136","key":"6044_CR15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3109\/10428199609052425","volume":"20","author":"SM Escudier","year":"1996","unstructured":"Escudier SM, Kantarjian HM, Estey EH (1996) Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid. Leuk Lymphoma 20(5\u20136):435\u2013439","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"6044_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.beha.2008.12.007","volume":"22","author":"E Stein","year":"2009","unstructured":"Stein E, McMahon B, Kwaan H, Altman JK, Frankfurt O, Tallman MS (2009) The coagulopathy of acute promyelocytic leukaemia revisited. Best Pract Res Clin Haematol 22(1):153\u2013163","journal-title":"Best Pract Res Clin Haematol"},{"key":"6044_CR17","doi-asserted-by":"publisher","unstructured":"Hambley BC, Tomuleasa C, Ghiaur G (2021) Coagulopathy in acute promyelocytic leukemia: can we go beyond supportive care? Front Med 8. https:\/\/doi.org\/10.3389\/fmed.2021.722614","DOI":"10.3389\/fmed.2021.722614"},{"issue":"4","key":"6044_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.thromres.2012.11.024","volume":"131","author":"A Rashidi","year":"2013","unstructured":"Rashidi A, Silverberg ML, Conkling PR, Fisher SI (2013) Thrombosis in acute promyelocytic leukemia. Thromb Res 131(4):281\u2013289. https:\/\/doi.org\/10.1016\/j.thromres.2012.11.024","journal-title":"Thromb Res"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06044-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-06044-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06044-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T01:11:00Z","timestamp":1735866660000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-06044-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["6044"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-06044-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2024,10,16]]},"assertion":[{"value":"8 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Registration"}},{"value":"Taken.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission to reproduce material from other sources"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}